Duality Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-155,267
| Closed | -$1.62M | – | 745 |
|
2023
Q4 | $1.62M | Buy |
+155,267
| New | +$1.62M | 0.17% | 219 |
|
2023
Q3 | – | Sell |
-316,056
| Closed | -$2.38M | – | 713 |
|
2023
Q2 | $2.38M | Buy |
316,056
+20,891
| +7% | +$157K | 0.3% | 123 |
|
2023
Q1 | $2.61M | Buy |
+295,165
| New | +$2.61M | 0.3% | 131 |
|
2022
Q4 | – | Sell |
-350,417
| Closed | -$2.83M | – | 774 |
|
2022
Q3 | $2.83M | Sell |
350,417
-27,619
| -7% | -$223K | 0.31% | 106 |
|
2022
Q2 | $2.84M | Buy |
+378,036
| New | +$2.84M | 0.28% | 124 |
|